Literature DB >> 22386818

Gastroprotective and toxicological evaluation of the Lithothamnion calcareum algae.

F Almeida1, L V Schiavo, A D Vieira, G L Araújo, C M Queiroz-Junior, M M Teixeira, G D Cassali, C A Tagliati.   

Abstract

Lithothamnion calcareum is a red alga of the Corallinacea family whose main feature is the formation of calcium carbonate precipitate in its cell walls. L. calcareum is marketed as a nutritional supplement for calcium and other minerals in Brazil and other countries under the pharmaceutical name of Vitality 50+. In this study, gastroprotective and pre-clinical toxicity assays were performed on this product. Doses of 30, 120 and 480 mg/kg were used in the gastroprotective study on Wistar rats. A dose of 2000 mg/kg was used in the preclinical acute toxicity study and oral doses of 1000 and 2000 mg/kg were used in the subchronic toxicity evaluation. L. calcareum played no significant role in the protection of the rats' gastric mucosa, nor did it cause increase in gastric irritation. No impact on the acute toxicity test was identified. In the subchronic toxicity test, serum levels of albumin, total protein and calcium decreased, and creatinine levels increased, suggesting hypercalcemia and possible kidney damage associated with liver damage, given that the majority of these parameters were irreversible. Thus, this work aims to discuss the relationship of the high concentration of calcium in the product with the observed effects.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22386818     DOI: 10.1016/j.fct.2012.02.028

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  3 in total

1.  Evaluation of acute and sub-chronic toxicity of lithothamnion sp. in mice and rats.

Authors:  Ying Zhang; Ruotao Tian; Haili Wu; Xuemin Li; Shuqin Li; Linxiu Bian
Journal:  Toxicol Rep       Date:  2020-07-15

2.  Feasibility single-arm study of a medical device containing Desmodium adscendens and Lithothamnium calcareum combined with chemotherapy in head and neck cancer patients.

Authors:  Luca Imperatori; Damiano Giardini; Gino Latini; Giuseppe Migliori; Claudio Blasi; Feisal Bunkheila; Cesare Breschi; Rodolfo Mattioli; Silvia Pelliccioni; Carmen Laurino; Maria Vadalà; Beniamino Palmieri; Tommaso Iannitti
Journal:  Cancer Manag Res       Date:  2018-11-08       Impact factor: 3.989

3.  Effect of Lithothamnium sp and calcium supplements in strain- and infection-induced bone resorption.

Authors:  Silvana Rodrigues de Albuquerque Taddei; Mila Fernandes Moreira Madeira; Izabella Lucas de Abreu Lima; Celso Martins Queiroz-Junior; Adriana Pedrosa Moura; Dauro Douglas Oliveira; Ildeu Andrade; Danielle da Glória Souza; Mauro Martins Teixeira; Tarcília Aparecida da Silva
Journal:  Angle Orthod       Date:  2014-04-15       Impact factor: 2.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.